For the quarter ending 2025-09-30, CUBB had $682,128K increase in cash & cash equivalents over the period. $106,436K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income from continuing operations | 75,745 | 73,851 |
| Provision for credit losses | 26,543 | 49,078 |
| Depreciation and amortization | 1,897 | 27,282 |
| Share-based compensation expense | 4,411 | 8,652 |
| Deferred taxes | -1,730 | -10,973 |
| Net amortization (accretion) of investment securities premiums and discounts | 1,185 | 1,773 |
| Unrealized (gain) loss on investment securities | 147 | 160 |
| Impairment loss on debt securities | 0 | -51,319 |
| Impairment loss on equity securities | 0 | 2,278 |
| Net (gain) loss on sale of investment securities | 186 | -1,797 |
| Unrealized gain on equity method investments | 0 | 0 |
| Unrealized (gain) loss on derivatives | 370 | 1,514 |
| (gain) loss on sale of leased assets under lessor operating leases | 221 | 1,636 |
| Fair value adjustment on loans held for sale | -108 | -378 |
| Fair value adjustment on loans held for investment | 228 | 2,050 |
| Net (gain) loss on sale of loans and leases | 0 | 2 |
| Origination and purchases of loans held for sale | 188,372 | 417,808 |
| Proceeds from the sales and repayments of loans held for sale | 206,068 | 466,171 |
| Amortization (accretion) of loan net deferred fees, discounts and premiums | -16,346 | -11,616 |
| Earnings on investment in bank-owned life insurance | 2,165 | 6,909 |
| (increase) decrease in accrued interest receivable and other assets | -3,063 | -3,465 |
| Increase (decrease) in accrued interest payable and other liabilities | 10,029 | 26,445 |
| Net cash provided by (used in) operating activities | 116,914 | 256,275 |
| Proceeds from maturities, calls and principal repayments of investment securities available for sale | 78,685 | 167,483 |
| Proceeds from maturities, calls and principal repayments of investment securities held to maturity | 63,031 | 155,580 |
| Proceeds from sales of investment securities available for sale | 100,914 | 450,423 |
| Purchases of investment securities available for sale | 295,705 | 506,771 |
| Purchases of investment securities held to maturity | 9,983 | 14,022 |
| Purchases of equity method investments | 0 | 0 |
| Origination of mortgage finance loans | 7,102,632 | 12,162,399 |
| Proceeds from repayments of mortgage finance loans | 7,151,408 | 11,969,037 |
| Net (increase) decrease in loans and leases, excluding mortgage finance loans | 803,319 | 461,034 |
| Proceeds from sales of loans and leases | 0 | 1,081 |
| Purchases of loans | 152,886 | 182,000 |
| Purchases of bank-owned life insurance | 0 | 1,462 |
| Proceeds from bank-owned life insurance | 0 | 5,634 |
| Net purchases from sale of fhlb, federal reserve bank, and other restricted stock | 2,700 | 4,376 |
| Purchases of bank premises and equipment | 10,478 | 772 |
| Proceeds from sale of other real estate owned | 118 | 0 |
| Proceeds from sales of leased assets under lessor operating leases | 6,884 | 4,207 |
| Purchases of leased assets under lessor operating leases | 48,998 | 39,811 |
| Net cash provided by (used in) investing activities | -1,025,661 | -619,202 |
| Net increase (decrease) in deposits | 1,428,381 | 101,644 |
| Net increase (decrease) in short-term borrowed funds from fhlb | -50,000 | - |
| Proceeds from long-term borrowed funds from fhlb and frb | 150,000 | 160,000 |
| Repayments of long-term borrowed funds from fhlb and frb | 100,000 | 100,000 |
| Repayments of other long-term borrowings | 0 | - |
| Redemption of preferred stock | 0 | 57,501 |
| Preferred stock dividends paid | 2,007 | 6,848 |
| Purchase of treasury stock | 0 | 5,641 |
| Payments of employee taxes withheld from share-based awards | 254 | 12,280 |
| Proceeds from issuance of common stock | 164,755 | 1,133 |
| Net cash provided by (used in) financing activities | 1,590,875 | 80,507 |
| Net increase (decrease) in cash and cash equivalents | 682,128 | -282,420 |
| Cash and cash equivalents at beginning of period | 3,785,931 | - |
| Cash and cash equivalents at end of period | 4,185,639 | - |
Customers Bancorp, Inc. (CUBB)
Customers Bancorp, Inc. (CUBB)